The prospective multiple-centre randomized controlled clinical study of high-dose amoxicillin-proton pump inhibitor dual therapy for < em > H. pylori < /em > infection in Sichuan areas

CONCLUSIONS: For the initial treatment of H. pylori infection, the high-dose dual therapy regimen has the same efficacy as the bismuth-containing quadruple therapy regimen, good compliance, less adverse reactions and high safety, so it can be recommended as the empirical first-line treatment regimen for the eradication of H. pylori (KY2019173).PMID:35098820 | DOI:10.1080/07853890.2022.2031269

Source: Annals of Medicine - January 31, 2022 Category: Internal Medicine Authors: Cheng Shen Changping Li Muhan Lv Xiaosong Dai Caiping Gao Liangping Li Qin Zhang Wen Pan Chao Liu Sijing Han Yang Zhang Shunbin Ding Hong Deng Yong Yao Jianyu Xu Mingyong Wei Haiyan Shi Peijie Yuan Xiaoyan Yang Yi Jian Jing Shan Yan Liu Zonghua Chen Xueji Source Type: research